APA (7th ed.) Citation

BA, D. O., AS, d. O. L., JPRC, B., LMR, A., ALR, d. F., RGM, R., . . . AD, D. S. (2025). Mitochondrial Dysfunction Induced by a Novel Salicylate-Based 1,2,3-Triazole Salt With Potent Antileishmanial Activity. Chemical biology & drug design, 106(6), e70227. https://doi.org/10.1111/cbdd.70227

Chicago Style (17th ed.) Citation

BA, De Oliveira, de Oliveira Lemos AS, Bastos JPRC, Antinarelli LMR, de Freitas ALR, Ribeiro RGM, da Silva Neto AF, Coimbra ES, and Da Silva AD. "Mitochondrial Dysfunction Induced by a Novel Salicylate-Based 1,2,3-Triazole Salt With Potent Antileishmanial Activity." Chemical Biology & Drug Design 106, no. 6 (2025): e70227. https://doi.org/10.1111/cbdd.70227.

MLA (9th ed.) Citation

BA, De Oliveira, et al. "Mitochondrial Dysfunction Induced by a Novel Salicylate-Based 1,2,3-Triazole Salt With Potent Antileishmanial Activity." Chemical Biology & Drug Design, vol. 106, no. 6, 2025, p. e70227, https://doi.org/10.1111/cbdd.70227.